CSPC Innovation Pharmaceutical (300765.SZ) completed a repurchase of 12.002 million shares at a cost of 321 million yuan.
New Noble (300765.SZ) announcement, as of September 20, 2024, the company has completed the share repurchase through special certificates...
CSPC Innovation Pharmaceutical (300765.SZ) announced that as of September 20, 2024, the company repurchased 12.002 million shares of the company through a special securities account for share repurchase using centralized bidding trading, accounting for 0.85% of the company's current total share capital. The highest transaction price was 34.99 yuan per share, the lowest transaction price was 18.68 yuan per share, and the total amount paid was 321 million yuan (excluding transaction costs). The buyback period has expired, and the buyback plan has been completed.
Related Articles

New Stock Preview | Everdisplay Optronics (688538.SH) goes public in Hong Kong to accelerate its exploration in the large-size AMOLED market.

Sinolink: Investment clues under the "15th Five-Year Plan" recommendations

Guotou Securities: HAIER SMARTHOME (06690) accelerates domestic sales growth in Q3, steadily increases exports, and the continuous effects of digital transformation are becoming more prominent.
New Stock Preview | Everdisplay Optronics (688538.SH) goes public in Hong Kong to accelerate its exploration in the large-size AMOLED market.

Sinolink: Investment clues under the "15th Five-Year Plan" recommendations

Guotou Securities: HAIER SMARTHOME (06690) accelerates domestic sales growth in Q3, steadily increases exports, and the continuous effects of digital transformation are becoming more prominent.

RECOMMEND

First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025

Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025

Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025


